| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Department of Veterans Affairs |
| Information provided by: | Department of Veterans Affairs |
| ClinicalTrials.gov Identifier: | NCT00012610 |
Purpose
Telepsychiatry is a novel means of providing expert psychiatric treatment to patients who live far from a source of care. If it can be demonstrated that treatment via telepsychiatry is as effective as in-person treatment, then many individuals with psychiatric illness will have easy access to psychiatric care, even if they live in geographically remote areas.
| Condition | Intervention |
|
Depression |
Procedure: Telepsychiatry |
| MedlinePlus related topics: | Depression |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
| Official Title: | Efficacy of Telepsychiatry in the Treatment of Depression |
| Estimated Enrollment: | 119 |
| Study Completion Date: | September 2000 |
| Arms | Assigned Interventions |
| 1 | Procedure: Telepsychiatry |
Background:
Telepsychiatry is a novel means of providing expert psychiatric treatment to patients who live far from a source of care. If it can be demonstrated that treatment via telepsychiatry is as effective as in-person treatment, then many individuals with psychiatric illness will have easy access to psychiatric care, even if they live in geographically remote areas.
Objectives:
The major goal of this study was to determine whether treatment of depressive disorders via telepsychiatry is as effective as in-person treatment. In addition, this study was designed to determine if depressed patients are as compliant and as satisfied with telepsychiatry as with in-person treatment. Another goal was to compare the cost and cost-effectiveness of remote treatment via telepsychiatry to in-person treatment.
Methods:
In this randomized controlled trial, veterans who presented with depression to any of three VA Maryland Health Care facilities with a SCID-IV depression diagnosis and a Hamilton Rating Scale for Depression (Ham-D) score of 16 or above were eligible for participation. Eligible veterans were randomized to either "in-person" treatment or "remote" treatment. Treatment occurred over six months and consisted of psychotropic medication and psycho-education concerning the disease, medications, and side effects. The major outcome variables included changes in Ham-D depression ratings and Beck Depression Inventory (BDI) self-reported depression ratings.
Status:
Completed.
Eligibility
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Depression, Hamilton 16 or above, SCID-IV depression diagnosis
Exclusion Criteria:
Contacts and Locations More Information
| Responsible Party: | Department of Veterans Affairs ( Ruskin, Paul - Principal Investigator ) |
| Study ID Numbers: | ACC 97-034 |
| First Received: | March 14, 2001 |
| Last Updated: | August 14, 2008 |
| ClinicalTrials.gov Identifier: | NCT00012610 |
| Health Authority: | United States: Federal Government |
|
|
